We found that high transcript levels of 3 genes – NSMCE2, MAL2 and EIF3H – significantly correlate with worse overall survival in breast cancer patients (Log-rank test, p-value < 0.05) (Fig. 2B). This evidence concerns the gene MAL2 and breast cancer.